Hyperlactatemia in human immunodeficiency virus-infected children receiving antiretroviral treatment

Pediatric Infectious Disease Journal

Volumn 22, Issue 9, 2003, Pages 778-782

  Noguera, Antoni ^a   Fortuny, Claudia ^a,c   Sanchez, Emilia ^b   Artuch, Rafael ^a   Vilaseca, Maria Antonia ^a   Muñoz Almagro, Carmen ^a   Pou, Jordi ^a   Jiménez, Rafael ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b C Agy Hlth Technol Assess Res   (Spain)

^c HOSPITAL SANT JOAN DE DÉU   (Spain)

Author keywords

Alanine; Human immunodeficiency virus infection; Hyperlactatemia; Mitochondrial toxicity; Nucleoside analogs; Pediatric

Indexed keywords

ABACAVIR; ALANINE; AMPRENAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; LACTIC ACID; LAMIVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; RITONAVIR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ADOLESCENT; AGE; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLACTATEMIA; INCIDENCE; INFANT; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC ACIDOSIS; MITOCHONDRION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL SIGNIFICANCE; SYMPTOM; VEIN PUNCTURE; VENOUS BLOOD;

ACIDOSIS, LACTIC; ADOLESCENT; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; ANTI-HIV AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INCIDENCE; INFANT; LACTATES; LACTIC ACID; MALE; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC;

EID: 0141570972     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000083826.11124.b1     Document Type: Article

References (26)

1. Côté HCF, Brumme ZL, Craib KJP, et al. Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. N Engl J Med 2002;346:811-20.
2. Brinkman K. Management of hyperlactatemia: no need for routine lactate measurements. AIDS 2001;15:795-7.
3. McComsey G, Tan DJ, Lederman M, et al. Analysis of the mitochondrial DNA genome in the peripheral blood leukocytes of HIV-infected patients with or without lipoatropy. AIDS 2002;16:513-8.
4. Bartley PB, Westacott L, Boots RJ, et al. Large hepatic mitochondrial DNA deletions associated with L-lactic acidosis and highly active antiretroviral therapy. AIDS 2001;15:419-20.
5. Brinkman K, Hofstede HJM, Burger DM, et al. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS 1998;12:1735-44.
6. Mokrzycki MH, Harris C, May H, et al. Lactic acidosis associated with stavudine administration: a report of five cases. Clin Infect Dis 2000;30:198-200.
7. Falco V, Rodriguez D, Ribera E, et al. Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature. Clin Infect Dis 2002;34:838-46.
8. John M, Moore CB, James IR, et al. Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy. AIDS 2001;15:717-23.
9. Boubaker K, Flepp M, Sudre P, et al. Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study. Clin Infect Dis 2001;33:1931-7.
10. Boffito M, Marietti G, Audagnotto S, et al. Lactacidemia in asymptomatic HIV-infected subjects receiving nucleoside reverse-transcriptase inhibitors. Clin Infect Dis 2002;15:558-9.
11. Coghlan ME, Sommadossi JP, Jhala NC, et al. Symptomatic lactic acidosis in hospitalized antiretroviral-treated patients with HIV: a report of 12 cases. Clin Infect Dis 2001;33:1914-21.
12. Lonergan JT, Behling C, Pfander H, et al. Hyperlactatemia and hepatic abnormalities in 10 human immunodeficiency virus-infected patients receiving nucleoside analogue combination regimens. Clin Infect Dis 2000;31:162-6.
13. Gérard Y, Maulin L, Yazdanpanah Y, et al. Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapy. AIDS 2000;14:2723-30.
14. Church JA, Mitchell WG, González-Gómez I, et al. Mitochondrial DNA depletion, near-fatal metabolic acidosis and liver failure in an HIV-infected child treated with combination antiretroviral therapy. J Pediatr 2001;138:748-51.
15. Lindegren ML, Rhodes P, Gordon L, et al. Drug safety during pregnancy and in infants: lack of mortality related to mitochondrial dysfunction among perinatally HIV-exposed children in pediatric HIV surveillance. Ann NY Acad Sci 2000;918:222-35.
16. Dominguez K, Bertolli J, Fowler M, et al. Lack of definitive severe mitochondrial signs and symptoms among deceased HIV-uninfected and HIV-indeterminate children ≤5 years of age, Pediatric Spectrum of HIV disease project (PSD), USA. Ann NY Acad Sci 2000;918:236-46.
17. Giaquinto C, Torresan S, Rampon O, et al. Lactic acid in infants perinatally exposed to antiretrovirals [Abstract 5940]. In: XIVth International AIDS Conference, Barcelona, July 7 to 12, 2002.
18. Blanche S, Tardieu M, Rustin P, et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 1999;354:1084-9.
19. Noguera A, Perez-Duenas B, Tello LM, et al. Lactic acidosis in newborns exposed to HIV and antiretrovirals [Abstract 5951]. In: XIVth International AIDS Conference, Barcelona, July 7 to 12, 2002.
20. Landreau-Mascaro A, Barret B, Mayaux MJ, et al. Risk of early febrile seizure with perinatal exposure to nucleoside analogues. Lancet 2002;359:583-4.
21. Artuch R, Vilaseca MA, Farre C, et al. Determination of lactate, pyruvate, beta-hydroxybutyrate and acetoacetate with a centrifugal analyser. Eur J Clin Chem Clin Biochem 1995;33:529-33.
22. Moyano D, Vilaseca MA, Artuch R, et al. Plasma amino acids in anorexia nervosa. Eur J Clin Nutr 1998;52:684-9.
23. Ruitenbeek W, Wendel U, Trijbels F, et al. Mitochondrial energy metabolism. In: Physician's guide to the laboratory diagnosis of metabolic diseases. London: Chapman & Hall, 1996:390-406.
24. Lonergan JT, Havlir DV, Barber E, et al. Incidence and outcome of hyperlactatemia associated with clinical manifestations in HIV-infected adults receiving NRTI-containing regimens [Abstract 624]. In: Eighth Conference on Retroviruses and Opportunistic Infections, Chicago, February 4 to 8, 2001.
25. Carr A, Miller J, Eisman JA, et al. Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy. AIDS 2001;15:703-9.
26. Munnich A. Defects of the respiratory chain. In: Inborn metabolic diseases: diagnosis and treatment. Berlin: Springer, 2000:158-68.